Flywheel Partners with Roche and Genentech to Accelerate Development of Personalized Healthcare Solutions


Flywheel, the leading cloud-scale informatics platform for biomedical research and collaboration, announced today the successful integration of its platform by Roche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation and analysis of medical imaging data.

The secure, scalable Flywheel platform enables aggregation and management of medical imaging and associated data to accelerate drug discovery. The data is organized and processed with automated pipelines—saving significant time and minimizing the potential for human error in the drug development process. Cost and timeline efficiencies allow researchers to focus on what matters most—bringing life-changing therapies to patients faster. Moreover, Flywheel’s unique approach has enabled multi-site collaboration and development of a customized solution for Roche and Genentech’s needs.

Read More

Next Post

Zing Health Recognized for Excellence in Medicare Advantage Benefits Value

Zing Health is one of 16 Medicare plans nationally to be recognized by HealthMetrix Research for cost-sharing insurance effectiveness. Zing Health’s Signature Care HMO plan, with a $0 premium and $0 annual deductible, is the only Medicare Advantage plan in the Indianapolis area achieving the designation Excellence in 2022 Medicare […]